Literature DB >> 25427913

Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers.

S Singh1, J Arcaroli, D C Thompson, W Messersmith, V Vasiliou.   

Abstract

Colorectal cancer (CRC) and pancreatic cancer are two very significant contributors to cancer-related deaths. Chronic alcohol consumption is an important risk factor for these cancers. Ethanol is oxidized primarily by alcohol dehydrogenases to acetaldehyde, an agent capable of initiating tumors by forming adducts with proteins and DNA. Acetaldehyde is metabolized by ALDH2, ALDH1B1, and ALDH1A1 to acetate. Retinoic acid (RA) is required for cellular differentiation and is known to arrest tumor development. RA is synthesized from retinaldehyde by the retinaldehyde dehydrogenases, specifically ALDH1A1, ALDH1A2, ALDH1A3, and ALDH8A1. By eliminating acetaldehyde and generating RA, ALDHs can play a crucial regulatory role in the initiation and progression of cancers. ALDH1 catalytic activity has been used as a biomarker to identify and isolate normal and cancer stem cells; its presence in a tumor is associated with poor prognosis in colon and pancreatic cancer. In summary, these ALDHs are not only biomarkers for CRC and pancreatic cancer but also play important mechanistic role in cancer initiation, progression, and eventual prognosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25427913      PMCID: PMC4347404          DOI: 10.1007/978-3-319-09614-8_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  90 in total

Review 1.  Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.

Authors:  C W Boone; G J Kelloff; W E Malone
Journal:  Cancer Res       Date:  1990-01-01       Impact factor: 12.701

2.  Aldh1L1 is expressed by postnatal neural stem cells in vivo.

Authors:  Lynette C Foo; Joseph D Dougherty
Journal:  Glia       Date:  2013-07-08       Impact factor: 7.452

3.  Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity.

Authors:  R W Storms; A P Trujillo; J B Springer; L Shah; O M Colvin; S M Ludeman; C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

4.  cDNA cloning and expression of a human aldehyde dehydrogenase (ALDH) active with 9-cis-retinal and identification of a rat ortholog, ALDH12.

Authors:  M Lin; J L Napoli
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

5.  Inhibition of intracolonic acetaldehyde production and alcoholic fermentation in rats by ciprofloxacin.

Authors:  J P Visapää; K Jokelainen; T Nosova; M Salaspuro
Journal:  Alcohol Clin Exp Res       Date:  1998-08       Impact factor: 3.455

6.  Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.

Authors:  Shan Deng; Xiaojun Yang; Heini Lassus; Shun Liang; Sippy Kaur; Qunrui Ye; Chunsheng Li; Li-Ping Wang; Katherine F Roby; Sandra Orsulic; Denise C Connolly; Youcheng Zhang; Kathleen Montone; Ralf Bützow; George Coukos; Lin Zhang
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

7.  Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

Authors:  Yu-Chih Chen; Yi-Wei Chen; Han-Shui Hsu; Ling-Ming Tseng; Pin-I Huang; Kai-Hsi Lu; Dow-Tien Chen; Lung-Kuo Tai; Ming-Chi Yung; Shih-Ching Chang; Hung-Hai Ku; Shih-Hwa Chiou; Wen-Liang Lo
Journal:  Biochem Biophys Res Commun       Date:  2009-05-18       Impact factor: 3.575

8.  Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

Authors:  Stephanie Ma; Kwok Wah Chan; Terence Kin-Wah Lee; Kwan Ho Tang; Jana Yim-Hung Wo; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

9.  Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma.

Authors:  Federico Colombo; Francesca Baldan; Silvia Mazzucchelli; Ines Martin-Padura; Paola Marighetti; Alessandra Cattaneo; Barbara Foglieni; Marta Spreafico; Silvana Guerneri; Marco Baccarin; Francesco Bertolini; Giorgio Rossi; Vincenzo Mazzaferro; Massimiliano Cadamuro; Marco Maggioni; Luca Agnelli; Paolo Rebulla; Daniele Prati; Laura Porretti
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

10.  The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis.

Authors:  Christel van den Hoogen; Geertje van der Horst; Henry Cheung; Jeroen T Buijs; Rob C M Pelger; Gabri van der Pluijm
Journal:  Clin Exp Metastasis       Date:  2011-06-07       Impact factor: 5.150

View more
  25 in total

1.  Adherence to the World Cancer Research Fund/American Institute for Cancer Research 2018 Recommendations for Cancer Prevention and Risk of Colorectal Cancer.

Authors:  Joshua Petimar; Stephanie A Smith-Warner; Bernard Rosner; Andrew T Chan; Edward L Giovannucci; Fred K Tabung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-24       Impact factor: 4.254

2.  Molecular mechanism of triple-negative breast cancer-associated BRCA1 and the identification of signaling pathways.

Authors:  Feng Qi; Wen-Xing Qin; Yuan-Sheng Zang
Journal:  Oncol Lett       Date:  2019-01-03       Impact factor: 2.967

3.  ALDH1B1 links alcohol consumption and diabetes.

Authors:  Surendra Singh; Ying Chen; Akiko Matsumoto; David J Orlicky; Hongbin Dong; David C Thompson; Vasilis Vasiliou
Journal:  Biochem Biophys Res Commun       Date:  2015-06-15       Impact factor: 3.575

4.  Environmental influences in the etiology of colorectal cancer: the premise of metabolomics.

Authors:  Nicholas J W Rattray; Georgia Charkoftaki; Zahra Rattray; James E Hansen; Vasilis Vasiliou; Caroline H Johnson
Journal:  Curr Pharmacol Rep       Date:  2017-04-07

5.  Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma.

Authors:  Xinwei Yun; Keqiang Zhang; Jinhui Wang; Rajendra P Pangeni; Lu Yang; Melissa Bonner; Jun Wu; Jami Wang; Isaac K Nardi; Ming Gao; Dan J Raz
Journal:  Mol Cancer Res       Date:  2018-05-02       Impact factor: 5.852

6.  Aberrant expression of ALDH1, MMP9, Integrin αvβ3, and KiSS-1 in invasive ductal carcinoma and their clinical significance.

Authors:  Xicheng Yue; Zhengquan Han; Ligong Zhang; Jing Li; Xiaomeng Gong
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

7.  Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular Carcinoma.

Authors:  Senbang Yao; Wenjun Chen; He Zuo; Ziran Bi; Xiuqing Zhang; Lulian Pang; Yanyan Jing; Xiangxiang Yin; Huaidong Cheng
Journal:  Biochem Genet       Date:  2021-12-20       Impact factor: 2.220

8.  Association of ALDH1 with Response to Radiotherapy and Its Impact on Survival in Patients with Advanced Stage of Head and Neck Squamous Cell Carcinoma (HNSCC).

Authors:  Parul Dubey; Narayan Kumar; Rajeev Gupta; Anupam Mishra; Smrati Bhadauriya; Vijay Kumar; Madanlal Brahma Bhatt
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

Review 9.  Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Jinhuang Chen; Qinghua Xia; Bin Jiang; Weilong Chang; Wenzheng Yuan; Zhijun Ma; Zhengyi Liu; Xiaogang Shu
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

10.  Characterizing drug-metabolizing enzymes and transporters that are bona fide CAR-target genes in mouse intestine.

Authors:  Shinhee Park; Sunny Lihua Cheng; Julia Yue Cui
Journal:  Acta Pharm Sin B       Date:  2016-08-02       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.